디지털 헬스 시장 : 예측(-2034년) - 컴포넌트별, 기술별, 용도별, 최종사용자별, 지역별 분석

According to Stratistics MRC, the Global Digital Health Market is accounted for $277.5 billion in 2026 and is expected to reach $1029.1 billion by 2034 growing at a CAGR of 17.8% during the forecast period. Digital health encompasses the convergence of digital technologies with healthcare to enhance efficiency, personalize treatment, and improve patient outcomes. This market includes mobile health applications, wearable devices, telehealth platforms, electronic health records, and artificial intelligence-driven diagnostic tools. By transforming how healthcare is delivered and consumed, digital health solutions are addressing critical challenges such as aging populations, rising chronic disease burdens, and the need for accessible, cost-effective care across both developed and emerging economies worldwide.

Market Dynamics:

Driver:

Accelerating adoption of telehealth and remote care models

The shift toward decentralized healthcare delivery is rapidly expanding digital health adoption as patients and providers recognize the convenience and cost savings of virtual consultations. Telehealth platforms reduce unnecessary hospital visits, minimize infection risks, and improve access for rural and mobility-limited populations. Health systems facing workforce shortages are leveraging remote monitoring and virtual care to extend provider reach while maintaining quality standards. Reimbursement policy changes in major markets, which permanently recognized telehealth parity following the pandemic, have solidified these services as standard offerings. This structural transformation continues to drive investment in digital infrastructure across all healthcare settings.

Restraint:

Interoperability challenges and fragmented data systems

The inability of different digital health platforms to seamlessly exchange patient data continues to limit the full potential of connected care. Electronic health records from various vendors often use incompatible standards, creating information silos that hinder coordinated treatment. Patients using multiple wellness apps and wearable devices encounter difficulties consolidating their health data into a unified view for providers. These fragmentation issues increase administrative burdens, risk data duplication, and can lead to incomplete clinical pictures. Healthcare organizations face significant costs and technical complexity when attempting to integrate disparate digital solutions, slowing the realization of truly connected, patient-centric ecosystems.

Opportunity:

Artificial intelligence integration for predictive analytics

Advanced AI algorithms are creating unprecedented opportunities to transform raw digital health data into actionable clinical insights. Machine learning models can analyze patterns from wearable sensors, electronic records, and genomic data to predict disease onset, recommend interventions, and personalize treatment protocols. Early warning systems for sepsis, diabetic complications, or cardiac events enable proactive rather than reactive care delivery. Pharmaceutical companies are leveraging AI-powered digital biomarkers to accelerate clinical trials and identify responsive patient subgroups. As computing costs decline and data volumes grow, AI-driven predictive capabilities will become accessible to smaller healthcare providers, democratizing advanced analytics across the industry.

Threat:

Data privacy and cybersecurity vulnerabilities

The proliferation of connected health devices and centralized patient data repositories creates expanding attack surfaces for malicious actors targeting sensitive medical information. Healthcare data commands premium prices on black markets due to its permanent nature and potential for identity theft, insurance fraud, or extortion. Ransomware attacks have crippled hospital operations, canceling procedures and endangering patient safety. Consumer wellness apps often lack robust security protections, exposing intimate health information. Regulatory penalties for breaches are increasing, while patient trust erodes with each high-profile incident. Organizations must continuously invest in evolving security measures, creating ongoing cost pressures that threaten smaller digital health providers.

Covid-19 Impact:

The pandemic acted as the single most powerful catalyst in digital health history, compressing a decade of expected adoption into mere months. Lockdowns forced healthcare systems to rapidly deploy telehealth infrastructure, with virtual visit volumes increasing by over 6,000% in some markets during early 2020. Regulatory barriers were temporarily suspended, reimbursement policies expanded, and both patients and clinicians overcame previous resistance to remote care. The crisis also accelerated development of contact tracing apps, remote monitoring for COVID patients, and AI-driven diagnostic tools. These behavioral and structural changes have proven largely durable, permanently elevating digital health from a supplementary option to a core component of healthcare delivery.

The Chronic Disease Management segment is expected to be the largest during the forecast period

The Chronic Disease Management segment is expected to account for the largest market share during the forecast period, driven by the global epidemic of diabetes, hypertension, cardiovascular disease, and respiratory conditions requiring continuous monitoring and intervention. Digital solutions including connected glucose monitors, smart inhalers, blood pressure cuffs, and medication adherence platforms enable patients to manage conditions outside clinical settings while providing providers with real-time data for timely adjustments. Aging populations in developed nations and rising lifestyle disease rates in emerging economies create sustained demand for these tools. Payers increasingly favor digital chronic care programs proven to reduce hospitalizations and emergency visits, ensuring this application maintains market leadership throughout the forecast timeline.

The Patients / Individuals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Patients / Individuals segment is predicted to witness the highest growth rate, reflecting the democratization of health management through consumer-friendly digital tools. Direct-to-consumer wearable devices, smartphone health applications, and home diagnostic kits empower individuals to take proactive control of their wellness without intermediary healthcare providers. This segment benefits from the proliferation of app stores, declining sensor costs, and growing health literacy among younger generations accustomed to on-demand information. Employers and insurers are increasingly subsidizing consumer digital health tools as preventive investments, further accelerating adoption. As personal health data becomes more actionable and integrated with clinical systems, individual users represent the fastest-growing end-user category.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by advanced healthcare IT infrastructure, favorable reimbursement policies, and high consumer technology adoption rates. The United States leads in digital health venture capital investment, with numerous innovative startups emerging from established tech ecosystems. Major electronic health record vendors and telehealth platforms are headquartered in the region, benefiting from early mover advantages. Regulatory bodies have implemented permanent telehealth flexibilities post-pandemic, ensuring continued market stability. High healthcare spending per capita and the prevalence of employer-sponsored wellness programs further drive digital health utilization across hospitals, clinics, and directly to consumers.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by rapidly digitizing healthcare systems, large underserved populations, and government smart health initiatives. Countries including China, India, and Southeast Asian nations are leapfrogging traditional healthcare infrastructure by deploying mobile-first digital solutions to reach rural communities. The region's massive smartphone penetration, improving internet connectivity, and growing middle class willing to pay for convenience create ideal conditions for telehealth and wellness app adoption. National digital health identification systems, such as India's Ayushman Bharat Digital Mission, provide foundational infrastructure. As international digital health companies expand into these markets and local competitors emerge, Asia Pacific becomes the fastest-growing regional market.

Key players in the market

Some of the key players in Digital Health Market include Teladoc Health, Inc., Siemens Healthineers AG, GE HealthCare Technologies Inc., Philips Healthcare, Cerner Corporation, Oracle Corporation, Epic Systems Corporation, Medtronic plc, Allscripts Healthcare Solutions, Inc., McKesson Corporation, IBM Corporation, Veradigm Inc., ResMed Inc., Agfa-Gevaert Group, and athenahealth, Inc.

Key Developments:

In March 2026, GE HealthCare Technologies Inc. completed the acquisition of Intelerad, a leader in medical imaging software, accelerating GE's shift toward a cloud-first enterprise imaging strategy.

In December 2025, Siemens Healthineers AG launched the Syngo Carbon enterprise imaging platform updates, integrating "one-click" AI analysis for cardiovascular disease detection across global hospital networks.

In July 2025, July 2025 secured CE Mark for the MiniMed(TM) 780G System, expanding its use to children as young as two and individuals with Type 2 diabetes, significantly widening its European market.

Components Covered:

• Hardware
• Software
• Services

Technologies Covered:

• Telehealthcare
• mHealth (Mobile Health)
• Healthcare Analytics
• Digital Health Systems

Applications Covered:

• Chronic Disease Management
• Wellness & Fitness
• Remote Patient Monitoring
• Diagnosis & Treatment
• Healthcare Management
• Preventive Healthcare
• Medication Management

End Users Covered:

• Healthcare Providers
• Patients / Individuals
• Payers
• Pharmaceutical & Biotechnology Companies
• Employers & Corporate Wellness Programs

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Digital Health Market, By Component

• 5.1 Hardware
  • 5.1.1 Wearable Devices
  • 5.1.2 Medical Devices & Monitoring Equipment
  • 5.1.3 Diagnostic Devices
• 5.2 Software
  • 5.2.1 Health Management Software
  • 5.2.2 EHR/EMR Software
  • 5.2.3 Telehealth Platforms
  • 5.2.4 Healthcare Analytics Software
  • 5.2.5 Mobile Health Applications
• 5.3 Services
  • 5.3.1 Consulting Services
  • 5.3.2 Integration & Deployment
  • 5.3.3 Training & Support
  • 5.3.4 Remote Monitoring Services

6 Global Digital Health Market, By Technology

• 6.1 Telehealthcare
  • 6.1.1 Teleconsultation
  • 6.1.2 Telemonitoring
  • 6.1.3 Tele-ICU
  • 6.1.4 Telecare
• 6.2 mHealth (Mobile Health)
  • 6.2.1 Wearables
  • 6.2.2 Mobile Apps
  • 6.2.3 Fitness Apps
  • 6.2.4 Medical Apps
• 6.3 Healthcare Analytics
  • 6.3.1 Predictive Analytics
  • 6.3.2 Descriptive Analytics
  • 6.3.3 Prescriptive Analytics
• 6.4 Digital Health Systems
  • 6.4.1 Electronic Health Records (EHR)
  • 6.4.2 E-Prescribing Systems
  • 6.4.3 Clinical Decision Support Systems (CDSS)
  • 6.4.4 Population Health Management

7 Global Digital Health Market, By Application

• 7.1 Chronic Disease Management
• 7.2 Wellness & Fitness
• 7.3 Remote Patient Monitoring
• 7.4 Diagnosis & Treatment
• 7.5 Healthcare Management
• 7.6 Preventive Healthcare
• 7.7 Medication Management

8 Global Digital Health Market, By End User

• 8.1 Healthcare Providers
  • 8.1.1 Hospitals
  • 8.1.2 Clinics
  • 8.1.3 Ambulatory Care Centers
• 8.2 Patients / Individuals
• 8.3 Payers
  • 8.3.1 Insurance Companies
  • 8.3.2 Government Organizations
• 8.4 Pharmaceutical & Biotechnology Companies
• 8.5 Employers & Corporate Wellness Programs

9 Global Digital Health Market, By Geography

• 9.1 North America
  • 9.1.1 United States
  • 9.1.2 Canada
  • 9.1.3 Mexico
• 9.2 Europe
  • 9.2.1 United Kingdom
  • 9.2.2 Germany
  • 9.2.3 France
  • 9.2.4 Italy
  • 9.2.5 Spain
  • 9.2.6 Netherlands
  • 9.2.7 Belgium
  • 9.2.8 Sweden
  • 9.2.9 Switzerland
  • 9.2.10 Poland
  • 9.2.11 Rest of Europe
• 9.3 Asia Pacific
  • 9.3.1 China
  • 9.3.2 Japan
  • 9.3.3 India
  • 9.3.4 South Korea
  • 9.3.5 Australia
  • 9.3.6 Indonesia
  • 9.3.7 Thailand
  • 9.3.8 Malaysia
  • 9.3.9 Singapore
  • 9.3.10 Vietnam
  • 9.3.11 Rest of Asia Pacific
• 9.4 South America
  • 9.4.1 Brazil
  • 9.4.2 Argentina
  • 9.4.3 Colombia
  • 9.4.4 Chile
  • 9.4.5 Peru
  • 9.4.6 Rest of South America
• 9.5 Rest of the World (RoW)
  • 9.5.1 Middle East
    • 9.5.1.1 Saudi Arabia
    • 9.5.1.2 United Arab Emirates
    • 9.5.1.3 Qatar
    • 9.5.1.4 Israel
    • 9.5.1.5 Rest of Middle East
  • 9.5.2 Africa
    • 9.5.2.1 South Africa
    • 9.5.2.2 Egypt
    • 9.5.2.3 Morocco
    • 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

• 10.1 Industry Value Network and Supply Chain Assessment
• 10.2 White-Space and Opportunity Mapping
• 10.3 Product Evolution and Market Life Cycle Analysis
• 10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

• 11.1 Mergers and Acquisitions
• 11.2 Partnerships, Alliances, and Joint Ventures
• 11.3 New Product Launches and Certifications
• 11.4 Capacity Expansion and Investments
• 11.5 Other Strategic Initiatives

12 Company Profiles

• 12.1 Teladoc Health, Inc.
• 12.2 Siemens Healthineers AG
• 12.3 GE HealthCare Technologies Inc.
• 12.4 Philips Healthcare
• 12.5 Cerner Corporation
• 12.6 Oracle Corporation
• 12.7 Epic Systems Corporation
• 12.8 Medtronic plc
• 12.9 Allscripts Healthcare Solutions, Inc.
• 12.10 McKesson Corporation
• 12.11 IBM Corporation
• 12.12 Veradigm Inc.
• 12.13 ResMed Inc.
• 12.14 Agfa-Gevaert Group
• 12.15 athenahealth, Inc.